Insights

AI Immunology Edge Evaxion is a clinical-stage TechBio company leveraging AI-Immunology to design novel vaccines and immunotherapies, signaling potential for partnerships in AI-driven vaccine platforms, personalized vaccines, and immunotherapy development collaborations.

Polio Vaccine Focus Recent collaboration with the Bill & Melinda Gates Foundation and announced AI-based polio vaccine design concepts present opportunities for funding-supported vaccine programs, advanced design concepts, and potential licensing or co-development deals.

Awarded Credibility Prix Galien UK Award for Best digital health solution and leadership recognition position Evaxion as a credible partner for enterprise and public health initiatives seeking innovative digital health and AI-enabled solutions.

Leadership & Growth Leadership expansions with a new Chief Scientific and Operating Officer indicate organizational scaling, presenting an opening for strategic partnerships, enterprise procurement, and joint development collaborations.

Global Outreach Active engagement in high-profile events like World Vaccine Congress and international award ceremonies suggests a strong networking channel for partnerships, grant opportunities, and potential multi-region distribution or research alliances.

Evaxion A/S Tech Stack

Evaxion A/S uses 8 technology products and services including html5media, gstatic.com, RSS, and more. Explore Evaxion A/S's tech stack below.

html5media

Audio, Video, Graphics

gstatic.com

Content Delivery Network

RSS

Content Management System

Continuous Delivery

Continuous Integration

ISO/IEC 27001

Governance, Risk And Compliance

HAProxy

Load Balancers

Priority Hints

Performance

Apache HTTP Server

Web Servers

Evaxion A/S Email Formats	Example	Percentage
Last@evaxion-biotech.com	Doe@evaxion-biotech.com	65%
FL@evaxion-biotech.com	JD@evaxion-biotech.com	35%
FL@evaxion.ai	JD@evaxion.ai	100%

Evaxion A/S Email Formats

Example

Percentage

Last@evaxion-biotech.com

Doe@evaxion-biotech.com

65%

FL@evaxion-biotech.com

JD@evaxion-biotech.com

35%

FL@evaxion.ai

JD@evaxion.ai

100%

Frequently Asked Questions

What is Evaxion A/S's official website and social media links?

Evaxion A/S's official website is evaxion.ai and has social profiles on LinkedIn Crunchbase.

How much revenue does Evaxion A/S generate?

As of July 2026, Evaxion A/S's annual revenue is estimated to be $1M - $10M.

What is Evaxion A/S's SIC code NAICS code?

Evaxion A/S's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evaxion A/S have currently?

As of July 2026, Evaxion A/S has approximately 51 employees across 2 continents, including EuropeNorth America. Key team members include Chief Financial Officer: T. F. S.Chief Ai Officer, Founder: A. H. M.Chief Scientific Officer: B. R.. Explore Evaxion A/S's employee directory with LeadIQ.

What industry does Evaxion A/S belong to?

Evaxion A/S operates in the Biotechnology Research industry.

What technology does Evaxion A/S use?

Evaxion A/S's tech stack includes html5mediagstatic.comRSSContinuous DeliveryISO/IEC 27001HAProxyPriority HintsApache HTTP Server.

What is Evaxion A/S's email format?

Evaxion A/S's email format typically follows the pattern of Last@evaxion-biotech.com. Find more Evaxion A/S email formats with LeadIQ.

How much funding has Evaxion A/S raised to date?

As of July 2026, Evaxion A/S has raised $114M in funding. The last funding round occurred on Oct 30, 2025 for $4.1M.

When was Evaxion A/S founded?

Evaxion A/S was founded in 2008.

Evaxion A/S

Q: What is Evaxion A/S's official website and social media links?

Evaxion A/S's official website is evaxion.ai. Evaxion A/S has social profiles on LinkedIn.

Q: How many employees does Evaxion A/S have currently?

Evaxion A/S has approximately 51 employees.

Q: What technology does Evaxion A/S use?

Evaxion A/S's tech stack includes JSZip, Azure Active Directory, X-XSS-Protection, libvirt, macOS.

Q: What is Evaxion A/S's NAICS code?

Evaxion A/S's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchHovedstaden, Denmark51-200 Employees

Evaxion A/S is a biotechnology research company based in Hørsholm, Denmark, focused on applying artificial intelligence to immunology. Its AI-Immunology platform is used to decode the human immune system in order to develop novel immunotherapies and vaccines for cancer, bacterial infections, and viral diseases, including personalized cancer vaccines and preclinical infectious disease programs. The company operates in a clinical-stage and preclinical space, targeting unmet medical needs by offering approaches that aim to design targeted treatments and vaccines. Its activities position it within the TechBio segment, combining computational methods with a focus on immune-related therapies. In addition to its core pipelines, Evaxion has engaged in collaborations and activities such as presenting AI-based vaccine design concepts and pursuing partnerships, including with the Gates Foundation, as part of its ongoing research and development efforts.

Insights

Similar companies to Evaxion A/S

Idorsia Pharmaceuticals Ltd

IO Biotech

GO Therapeutics

Immunovia AB

Evaxion A/S Tech Stack

Media & News

Evaxion attended event ESMO Congress 2026 on Jan 1st '26.

Evaxion will attend event European Society for Medical Oncology (ESMO) Congress 2026 on Oct 23rd '26.

Evaxion attended event International Herpesvirus Workshop (IHW) 2026 on Jul 11th '26.

Helen-Tayton Martin at Evaxion received award Prix Galien UK Award for Best digital health solution at Prix Galien UK Awards on Jun 12th '26.

Evaxion attended event Prix Galien UK Awards on Jun 12th '26.

Evaxion promoted Birgitte Rønø to Chief Scientific and Chief Operating Officer on Apr 27th '26.

Evaxion partners with Bill & Melinda Gates Foundation.

Evaxion A/S's Email Address Formats